Clomid Vs Enclomiphene Differences For Men With Low T

Clomid and enclomiphene are close cousins, which is exactly why the choice between them trips people up. Clomid vs enclomiphene comes down to one molecule split two ways. Clomid (clomiphene citrate) is a mixture of roughly 62% enclomiphene and 38% zuclomiphene, while enclomiphene is the purified active isomer on its own (Wiehle et al., 2013). Both are selective estrogen receptor modulators (SERMs) prescribed off-label for men with secondary hypogonadism, and neither is FDA-approved to treat low testosterone in men.

These medications draw interest from men who want to address low testosterone while keeping fertility intact, an option that sits apart from injections through men's telehealth hormone care. The comparison is really between two ways of prompting the body to make more of its own testosterone. A provider reads the labs and symptoms first, then decides whether either drug fits.

What follows covers how the two differ, what the research actually shows, and where each one tends to land in practice. It does not cover dosing, because that belongs with a provider and a man's own lab results.

What are Clomid and enclomiphene?

Clomid and enclomiphene are both selective estrogen receptor modulators that raise testosterone by lifting estrogen's brake on the brain's hormone signals. Clomid is the older mixed-isomer drug, FDA-approved for inducing ovulation in women, with use in men that has always been off-label (Wiehle et al., 2013). Enclomiphene is the isolated active isomer, studied for secondary hypogonadism under the trial name Androxal (Wiehle et al., 2013).

No enclomiphene product reached the market with FDA approval, so it is supplied through compounding pharmacies, and compounded medications are not FDA-approved. Marek Health publishes separate enclomiphene dosing guidance for men who want the detail.

The split matters because of the second isomer. Zuclomiphene, the cis form left out of enclomiphene, has a much longer half-life and weak estrogen-like activity, so it lingers in the body and is thought to drive several of clomiphene's side effects (Wiehle et al., 2013).

How do Clomid and enclomiphene work?

Both drugs block estrogen receptors in the hypothalamus, which removes the feedback signal telling the brain to slow hormone output. The pituitary then releases more luteinizing hormone (LH) and follicle-stimulating hormone (FSH), and those signals push the testes to make more testosterone (Wiehle et al., 2013; Mulhall et al., 2018).

That route is why SERMs may help preserve fertility. Because the stimulus runs through a man's own hormonal axis, sperm production is often maintained, though this varies. Exogenous testosterone, including injectable testosterone esters, does the opposite and suppresses it. The trade-off is central to why some men choose a SERM at all.

The core differences between Clomid and enclomiphene

The drugs share a mechanism but differ in composition, estrogen behavior, and the evidence behind them. The table sets the practical contrasts side by side.

Which option has fewer side effects?

Enclomiphene may be the better-tolerated of the two, though the head-to-head evidence is thin. A 2024 retrospective study of hypogonadal men found enclomiphene raised testosterone by an amount similar to clomiphene, with no statistically significant difference between the drugs, while producing a smaller rise in estradiol and fewer documented adverse events, including reports of reduced libido, lower energy, and mood changes (Saffati et al., 2024).

The likely reason traces back to zuclomiphene. Its estrogen-like activity and long half-life are associated with the estrogenic effects men report on clomiphene, such as mood shifts and changes in libido. Removing it is the whole point of enclomiphene. Men already dealing with high estradiol may find this distinction matters more than it would for someone without that sensitivity.

What the studies show on testosterone and fertility

SERMs can raise testosterone while supporting sperm production. A 2025 systematic review and meta-analysis of randomized trials found clomiphene and enclomiphene increased total testosterone compared with placebo, with no statistically significant difference from testosterone gel, and with spermatogenesis preserved in the trials reviewed (Hohl et al., 2025). That fertility signal is the practical dividing line from standard testosterone replacement.

Guidelines point the same direction. The AUA notes that men with low or low-normal LH can be considered for SERM use, particularly those wishing to preserve fertility (Mulhall et al., 2018). Even so, fertility effects vary between individuals and are not guaranteed, which is why lab testing and follow-up belong in any plan. Response itself is variable, and not every man reaches an adequate testosterone level.

How providers choose between Clomid and enclomiphene

The decision rests on labs, symptoms, estrogen sensitivity, cost, access, and how a given man responds. There is no single right answer, and the choice is best made through shared decision-making with a licensed provider, who evaluates a man before any prescription. Neither drug is appropriate for raising testosterone purely for aging, since that is not an approved use.

Cost and availability still favor clomiphene for many men, while enclomiphene's cleaner estrogen profile appeals to those who react poorly to the older drug. Because compounded enclomiphene is not FDA-approved, sourcing and provider oversight matter. A frank provider evaluation, not a self-guided guess, sorts out which path fits.

Is enclomiphene the better choice for raising testosterone?

For men sensitive to estrogen-related effects, enclomiphene's profile is appealing, but the available data suggest it does not clearly out-perform clomiphene on testosterone itself. Based on limited retrospective evidence, the apparent edge is tolerability rather than potency (Saffati et al., 2024). Many men respond well to clomiphene at lower cost. The sharper question in the Clomid vs enclomiphene debate is often whether a SERM fits at all, since men with primary hypogonadism, where the testes themselves have failed, will not respond because there is no working axis to drive. That answer comes from testing and a provider, not from the label on a bottle.

Disclaimer: This blog post is intended for informational purposes only and should not be considered medical advice. Always consult a healthcare professional before making changes to your health routine.

FAQs

What is the main difference between Clomid and enclomiphene? 

Clomid (clomiphene citrate) is a mixture of about 62% enclomiphene and 38% zuclomiphene, while enclomiphene is the purified active isomer on its own (Wiehle et al., 2013). Both are selective estrogen receptor modulators used off-label in men with secondary hypogonadism. The main practical difference is that enclomiphene leaves out the zuclomiphene linked to estrogenic side effects.

Which has fewer side effects, Clomid or enclomiphene? 

Available research points to enclomiphene. A 2024 retrospective study found enclomiphene produced a smaller rise in estradiol and fewer documented adverse events than clomiphene, including reports of reduced libido, lower energy, and mood changes (Saffati et al., 2024). The suspected reason is the absence of zuclomiphene, which has a long half-life and weak estrogen-like activity.

Are Clomid and enclomiphene FDA-approved for low testosterone? 

No. Clomiphene citrate is FDA-approved only for inducing ovulation in women, and its use in men is off-label (Wiehle et al., 2013). Enclomiphene has no FDA-approved product, and compounded enclomiphene is not FDA-approved either.

Do Clomid and enclomiphene preserve fertility? 

Both may help preserve fertility because they raise testosterone through the body's own hormonal axis rather than replacing it. A 2025 meta-analysis reported that these SERMs increased testosterone while preserving spermatogenesis in the trials reviewed (Hohl et al., 2025). Fertility effects vary between individuals and are not guaranteed.

Clomid vs enclomiphene, which raises testosterone more? 

Probably not by a meaningful margin. In a 2024 retrospective comparison the testosterone increase was similar between the two, with no statistically significant difference (Saffati et al., 2024). In that study, enclomiphene's advantage was tolerability rather than a larger testosterone rise.

Clomid vs enclomiphene, who is a candidate? 

The AUA notes that men with low or low-normal LH can be considered for SERM use, particularly those wishing to preserve fertility (Mulhall et al., 2018). Men with primary hypogonadism, where the testes have failed, generally will not respond. A licensed provider determines suitability after lab testing.

References

• Arch Endocrinol Metab. 2025;69(5):e250093

• BJU Int. 2013;112(8):1188–1200

• J Urol. 2018;200(2):423–432

• Transl Androl Urol. 2024;13(9):1984–1990